C E Voss - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C E Voss

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Hospital Forum|October 9, 1977

Developing your hospital's biomedical engineering skillsW R Schneider, C E Voss

Cancer Research|August 21, 2025

Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer ProgressionVaradha Balaji Venkadakrishnan, Adam Presser, Nathaniel C E Voss, et al.

Nature Communications|August 8, 2024

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Hospital Forum|October 9, 1977

Developing your hospital's biomedical engineering skillsW R Schneider, C E Voss

Cancer Research|August 21, 2025

Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer ProgressionVaradha Balaji Venkadakrishnan, Adam Presser, Nathaniel C E Voss, et al.

Nature Communications|August 8, 2024

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.

Pageof 1